Clinical Trial Update: Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes an antiangiogenic therapy for children with recurrent medulloblastoma, ependymoma, ATRT, and other rare CNS tumors, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Central Nervous System Tumor
• Ependymoma
• Medulloblastoma

Snippet

Sponsor: Medical University of Vienna | Conditions: Medulloblastoma Recurrent, Ependymoma Recurrent | Phase 2 | Status: RECRUITING